330 articles in this topic
A deep mechanistic exploration of neutrophil extracellular trap biology in the context of aging — from PAD4 citrullination dynamics and gasdermin-driven release to clinical immunopathology and next-generation therapeutic targets.
Researchers discover LEF1 marks true self-renewing T cells in autoimmunity and chronic infection, opening new therapeutic targets.
A massive viral gene library exposes hundreds of proteins that suppress immune detection — with major implications for infection, cancer, and aging.
Authors reply to commentary on a landmark NEJM trial combining ianalumab and eltrombopag for immune thrombocytopenia.
Five decades after Ebola's discovery, leading virologists assess what works, what fails, and what must change in global outbreak preparedness.
Researchers outline the critical knowledge gaps blocking effective response to Bundibugyo ebolavirus, a rare but lethal filovirus.
New research suggests latent HIV hides in more T cell types than known, reshaping strategies for an HIV cure.
A new naloxone nasal spray receives FDA approval, expanding access to life-saving opioid reversal treatment.
The WHO has issued landmark guidelines standardizing care for two of the world's deadliest viral hemorrhagic fevers.
Experts argue that finding new autoantibodies in encephalitis is yielding diminishing returns and call for a shift in research priorities.
A Nature Medicine commentary reviews the accelerating pipeline of Lassa fever countermeasures, signaling progress against a deadly viral hemorrhagic disease.
Go deeper into the molecular machinery of neutrophil extracellular traps — how they form, what activates them with age, and why clearing them becomes increasingly difficult over time.
